2025-08-20 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
2,258,400 |
2,243,659 |
|
|
|
2025-08-18 |
13G
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
2,438,964 |
9,611,751 |
|
|
|
2025-08-14 |
13G/A
|
VERV / Verve Therapeutics, Inc.
|
|
6,904,050 |
0 |
|
|
|
2025-08-14 |
13G/A
|
VIGL / Vigil Neuroscience, Inc.
|
|
4,734,500 |
0 |
|
|
|
2025-08-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
1,417,117 |
|
|
|
2025-08-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
3,075,000 |
0 |
|
|
|
2025-08-14 |
13G/A
|
IMUX / Immunic, Inc.
|
|
8,902,972 |
9,785,178 |
|
|
|
2025-08-14 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
0 |
1,387,863 |
|
|
|
2025-08-13 |
13G/A
|
VSTM / Verastem, Inc.
|
|
4,706,551 |
2,500,000 |
|
|
|
2025-08-13 |
13G/A
|
VSTM / Verastem, Inc.
|
|
4,706,551 |
5,720,831 |
|
|
|
2025-08-07 |
13D/A
|
EPIX / ESSA Pharma Inc.
|
|
8,748,629 |
11,668,473 |
|
|
|
2025-07-21 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
3,853,818 |
0 |
|
|
|
2025-07-09 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
8,089,795 |
5,769,231 |
|
|
|
2025-07-09 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
8,089,795 |
11,538,462 |
|
|
|
2025-07-09 |
13G
|
NKTR / Nektar Therapeutics
|
|
|
1,276,595 |
|
|
|
2025-06-16 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,970,427 |
3,211,041 |
|
|
|
2025-05-20 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
2,983,026 |
2,590,303 |
|
|
|
2025-05-19 |
13G/A
|
ALLK / Allakos Inc.
|
|
16,552,417 |
0 |
|
|
|
2025-05-15 |
13G/A
|
VIGL / Vigil Neuroscience, Inc.
|
|
2,739,727 |
4,734,500 |
|
|
|
2025-05-15 |
13G/A
|
TCRX / TScan Therapeutics, Inc.
|
|
5,073,003 |
5,263,541 |
|
|
|
2025-05-15 |
13G/A
|
SEPN / Septerna, Inc.
|
|
2,452,024 |
4,396,124 |
|
|
|
2025-05-15 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
2,325,000 |
3,075,000 |
|
|
|
2025-05-15 |
13G/A
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
4,393,210 |
5,660,132 |
|
|
|
2025-05-15 |
13G/A
|
GHRS / GH Research PLC
|
|
10,400,158 |
8,827,712 |
|
|
|
2025-05-15 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
4,834,297 |
4,632,749 |
|
|
|
2025-05-15 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
6,230,845 |
4,440,000 |
|
|
|
2025-05-15 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
1,093,499 |
1,252,441 |
|
|
|
2025-05-09 |
13D/A
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
8,545,499 |
8,545,499 |
|
|
|
2025-04-16 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
2,372,933 |
0 |
|
|
|
2025-04-09 |
13D
|
EPIX / ESSA Pharma Inc.
|
|
8,748,629 |
8,748,629 |
|
|
|
2025-02-14 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
2,777,245 |
3,084,324 |
|
|
|
2025-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
4,279,521 |
4,706,551 |
|
|
|
2025-02-14 |
13G/A
|
TYRA / Tyra Biosciences, Inc.
|
|
4,661,194 |
3,944,194 |
|
|
|
2025-02-14 |
13G/A
|
IKNA / Ikena Oncology, Inc.
|
|
4,769,164 |
4,006,564 |
|
|
|
2025-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
7,382,642 |
4,834,297 |
|
|
|
2025-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
2,982,105 |
643,622 |
|
|
|
2025-02-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
6,811,631 |
4,333,885 |
|
|
|
2025-02-14 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
703,126 |
1,093,499 |
|
|
|
2025-02-14 |
13G/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
967,299 |
1,038,542 |
|
|
|
2025-02-04 |
13G
|
KURA / Kura Oncology, Inc.
|
|
4,212,346 |
5,912,554 |
|
|
|
2025-02-04 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
4,212,346 |
3,408,054 |
|
|
|
2025-01-31 |
13G
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
4,393,210 |
|
|
|
2025-01-29 |
13G/A
|
ENGN / enGene Holdings Inc.
|
|
3,196,439 |
945,402 |
|
|
|
2025-01-29 |
13G/A
|
ENGN / enGene Holdings Inc.
|
|
3,196,439 |
3,051,439 |
|
|
|
2025-01-28 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
3,633,743 |
2,983,026 |
|
|
|
2025-01-06 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
11,764,000 |
|
|
|
2024-12-23 |
13D/A
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
8,545,499 |
8,545,499 |
|
|
|
2024-12-17 |
13G/A
|
PVLA / Palvella Therapeutics, Inc.
|
|
|
1,168,117 |
|
|
|
2024-12-04 |
13D/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
9,135,893 |
7,557,237 |
|
|
|
2024-11-21 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
1,259,476 |
2,325,000 |
|
|
|
2024-11-18 |
13G
|
VERV / Verve Therapeutics, Inc.
|
|
|
6,904,050 |
|
|
|
2024-11-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
2,617,402 |
4,279,521 |
|
|
|
2024-11-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
6,851,051 |
3,853,818 |
|
|
|
2024-11-14 |
13G/A
|
TCRX / TScan Therapeutics, Inc.
|
|
4,414,910 |
5,073,003 |
|
|
|
2024-11-14 |
13G/A
|
ANNX / Annexon, Inc.
|
|
7,000,000 |
9,027,778 |
|
|
|
2024-11-14 |
13G/A
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
4,370,024 |
3,075,907 |
|
|
|
2024-11-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
537,426 |
672,767 |
|
|
|
2024-11-14 |
13G/A
|
ACIU / AC Immune SA
|
|
14,571,236 |
19,522,436 |
|
|
|
2024-11-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
3,833,785 |
0 |
|
|
|
2024-11-14 |
13G/A
|
TYRA / Tyra Biosciences, Inc.
|
|
2,739,595 |
4,661,194 |
|
|
|
2024-11-14 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
3,347,946 |
0 |
|
|
|
2024-11-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
9,661,235 |
883,844 |
|
|
|
2024-11-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
7,373,228 |
4,212,346 |
|
|
|
2024-11-14 |
13G/A
|
ANTX / AN2 Therapeutics, Inc.
|
|
1,563,963 |
0 |
|
|
|
2024-11-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
7,568,480 |
6,811,631 |
|
|
|
2024-11-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
5,763,948 |
2,970,427 |
|
|
|
2024-11-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
4,450,885 |
6,230,845 |
|
|
|
2024-11-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
3,470,225 |
10,471,230 |
|
|
|
2024-11-14 |
13G/A
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
24,435,632 |
0 |
|
|
|
2024-11-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
6,702,889 |
8,089,795 |
|
|
|
2024-11-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
5,870,000 |
4,607,935 |
|
|
|
2024-11-14 |
13G/A
|
JANX / Janux Therapeutics, Inc.
|
|
4,579,818 |
0 |
|
|
|
2024-11-14 |
13G/A
|
CGEM / Cullinan Therapeutics, Inc.
|
|
4,393,321 |
5,796,433 |
|
|
|
2024-11-14 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
9,275,527 |
703,126 |
|
|
|
2024-11-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
3,479,043 |
1,409,993 |
|
|
|
2024-11-14 |
13G/A
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
8,774,570 |
0 |
|
|
|
2024-11-14 |
13G/A
|
DCTH / Delcath Systems, Inc.
|
|
2,338,426 |
1,041,667 |
|
|
|
2024-11-13 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
4,007,413 |
7,382,642 |
|
|
|
2024-11-12 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
4,365,933 |
2,372,933 |
|
|
|
2024-11-01 |
13G
|
SEPN / Septerna, Inc.
|
|
|
2,452,024 |
|
|
|
2024-10-31 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
4,326,710 |
6,293,282 |
|
|
|
2024-10-31 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
4,326,710 |
6,293,282 |
|
|
|
2024-10-29 |
13D/A
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
8,696,205 |
9,888,592 |
|
|
|
2024-10-21 |
13D/A
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
8,545,499 |
8,545,499 |
|
|
|
2024-10-08 |
13D/A
|
MLTX / MoonLake Immunotherapeutics
|
|
21,751,284 |
19,751,284 |
|
|
|
2024-09-11 |
13G/A
|
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
|
|
6,260,311 |
0 |
|
|
|
2024-08-23 |
13G
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
967,299 |
|
|
|
2024-08-19 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
340,660 |
|
|
|
2024-07-19 |
13D/A
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
8,545,499 |
8,545,499 |
|
|
|
2024-06-10 |
13G
|
CELC / Celcuity Inc.
|
|
|
3,466,000 |
|
|
|
2024-05-30 |
13G
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
5,552,341 |
|
|
|
2024-05-17 |
13G
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
20,609,863 |
257,622 |
|
|
|
2024-05-17 |
13G
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
20,609,863 |
257,622 |
|
|
|
2024-03-05 |
13D/A
|
MLTX / MoonLake Immunotherapeutics
|
|
21,751,284 |
21,751,284 |
|
|
|
2024-02-22 |
13G/A
|
ENGN / enGene Holdings Inc.
|
|
3,196,439 |
3,196,439 |
|
|
|
2024-02-14 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
3,360,941 |
0 |
|
|
|
2024-02-14 |
13G/A
|
RNTX / Rein Therapeutics Inc.
|
|
236,835 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ANNX / Annexon, Inc.
|
|
3,780,694 |
7,000,000 |
|
|
|
2024-02-14 |
13G/A
|
ARAV / Aravive, Inc.
|
|
6,109,058 |
8,164,510 |
|
|
|
2024-02-14 |
13G/A
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
43,344,975 |
|
|
|
2024-02-14 |
13G/A
|
BNOX / Bionomics Limited - Depositary Receipt (Common Stock)
|
|
170,089,885 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
6,861,127 |
9,275,527 |
|
|
|
2024-02-14 |
13G/A
|
CGEM / Cullinan Therapeutics, Inc.
|
|
7,509,059 |
4,393,321 |
|
|
|
2024-02-14 |
13G/A
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
6,894,345 |
8,774,570 |
|
|
|
2024-02-14 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
2,736,613 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
6,595,801 |
6,702,889 |
|
|
|
2024-02-14 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
2,326,710 |
4,326,710 |
|
|
|
2024-02-14 |
13G/A
|
DCTH / Delcath Systems, Inc.
|
|
1,561,514 |
2,338,426 |
|
|
|
2024-02-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
2,312,200 |
4,450,885 |
|
|
|
2024-02-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
3,521,126 |
7,568,480 |
|
|
|
2024-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
4,007,413 |
4,007,413 |
|
|
|
2024-02-14 |
13G/A
|
GHRS / GH Research PLC
|
|
9,275,158 |
10,400,158 |
|
|
|
2024-02-14 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
1,739,670 |
0 |
|
|
|
2024-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
2,455,089 |
3,479,043 |
|
|
|
2024-02-14 |
13G/A
|
IKNA / Ikena Oncology, Inc.
|
|
2,503,071 |
4,769,164 |
|
|
|
2024-02-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
1,810,835 |
1,259,476 |
|
|
|
2024-02-14 |
13G/A
|
JANX / Janux Therapeutics, Inc.
|
|
4,106,945 |
4,579,818 |
|
|
|
2024-02-14 |
13G/A
|
/ JASPER THERAPEUTICS INC
|
|
9,900,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
3,800,983 |
7,373,228 |
|
|
|
2024-02-14 |
13G/A
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
16,149,179 |
24,435,632 |
|
|
|
2024-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
2,978,420 |
2,752,420 |
|
|
|
2024-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
537,426 |
|
|
|
2024-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
5,025,900 |
5,763,948 |
|
|
|
2024-02-14 |
13G/A
|
PYXS / Pyxis Oncology, Inc.
|
|
2,938,851 |
0 |
|
|
|
2024-02-14 |
13G/A
|
RVMD / Revolution Medicines, Inc.
|
|
7,555,588 |
5,981,212 |
|
|
|
2024-02-14 |
13G/A
|
TYRA / Tyra Biosciences, Inc.
|
|
2,472,327 |
2,739,595 |
|
|
|
2024-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
2,302,094 |
0 |
|
|
|
2024-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
|
2,617,402 |
|
|
|
2024-01-29 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
3,526,729 |
0 |
|
|
|
2024-01-29 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
9,544,262 |
9,544,262 |
|
|
|
2024-01-18 |
13G/A
|
ALLK / Allakos Inc.
|
|
5,006,921 |
16,552,417 |
|
|
|
2024-01-18 |
13G/A
|
ALLK / Allakos Inc.
|
|
5,006,921 |
8,552,417 |
|
|
|
2024-01-18 |
13G
|
IMUX / Immunic, Inc.
|
|
|
8,902,972 |
|
|
|
2024-01-16 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
3,530,543 |
3,633,743 |
|
|
|
2024-01-09 |
13D/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
4,692,604 |
5,831,171 |
|
|
|
2023-12-20 |
13D/A
|
PNT / POINT Biopharma Global Inc.
|
|
17,437,375 |
0 |
|
|
|
2023-12-20 |
13G/A
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
12,660,518 |
2,438,964 |
|
|
|
2023-12-19 |
13G/A
|
ACIU / AC Immune SA
|
|
7,428,379 |
14,571,236 |
|
|
|
2023-12-18 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
3,526,729 |
3,526,729 |
|
|
|
2023-12-04 |
13G
|
SABS / SAB Biotherapeutics, Inc.
|
|
|
9,178,282 |
|
|
|
2023-11-20 |
13D
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
6,492,517 |
8,696,205 |
|
|
|
2023-11-17 |
13D/A
|
RPTX / Repare Therapeutics Inc.
|
|
9,098,600 |
10,333,600 |
|
|
|
2023-11-13 |
13G
|
ENGN / enGene Holdings Inc.
|
|
|
3,196,439 |
|
|
|
2023-11-07 |
13G/A
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
4,510,072 |
6,492,517 |
|
|
|
2023-11-06 |
13D
|
PNT / POINT Biopharma Global Inc.
|
|
9,177,748 |
17,437,375 |
|
|
|
2023-11-03 |
13D
|
RPTX / Repare Therapeutics Inc.
|
|
8,291,988 |
9,098,600 |
|
|
|
2023-10-16 |
13G
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
2,777,245 |
|
|
|
2023-09-25 |
13D/A
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
|
8,545,499 |
|
|
|
2023-09-18 |
13G
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
4,370,024 |
|
|
|
2023-09-14 |
13D/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
7,411,503 |
9,135,893 |
|
|
|
2023-08-17 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
3,526,729 |
3,526,729 |
|
|
|
2023-08-17 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
20,609,863 |
20,609,863 |
|
|
|
2023-08-10 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
0 |
2,982,105 |
|
|
|
2023-07-06 |
13G
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
3,470,225 |
|
|
|
2023-06-30 |
13D/A
|
MLTX / MoonLake Immunotherapeutics
|
|
21,751,284 |
21,751,284 |
|
|
|
2023-06-30 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
1,810,549 |
7,555,588 |
|
|
|
2023-06-28 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
28,463,021 |
0 |
|
|
|
2023-06-22 |
13G
|
DCTH / Delcath Systems, Inc.
|
|
|
1,561,514 |
|
|
|
2023-06-05 |
13G
|
TCRX / TScan Therapeutics, Inc.
|
|
|
4,414,910 |
|
|
|
2023-05-30 |
13G
|
JANX / Janux Therapeutics, Inc.
|
|
|
4,106,945 |
|
|
|
2023-05-22 |
13D
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
7,694,060 |
20,609,863 |
|
|
|
2023-03-24 |
13G
|
IDYA / IDEAYA Biosciences, Inc.
|
|
2,205,089 |
2,455,089 |
|
|
|
2023-03-20 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
1,250,000 |
5,025,900 |
|
|
|
2023-03-16 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
3,276,543 |
3,360,941 |
|
|
|
2023-03-06 |
13G
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
42,440,000 |
|
|
|
2023-02-14 |
13G/A
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
4,526,282 |
4,510,072 |
|
|
|
2023-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
1,964,859 |
2,205,089 |
|
|
|
2023-02-14 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
1,799,694 |
1,739,670 |
|
|
|
2023-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
4,135,071 |
2,978,420 |
|
|
|
2023-02-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
3,898,000 |
3,521,126 |
|
|
|
2023-02-14 |
13G/A
|
PNT / POINT Biopharma Global Inc.
|
|
5,590,048 |
9,177,748 |
|
|
|
2023-02-14 |
13G/A
|
RCUS / Arcus Biosciences, Inc.
|
|
3,960,948 |
2,303,520 |
|
|
|
2023-02-14 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
3,003,879 |
2,736,613 |
|
|
|
2023-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
1,647,400 |
0 |
|
|
|
2023-02-14 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
3,114,532 |
984,824 |
|
|
|
2023-02-14 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
4,931,879 |
1,451,197 |
|
|
|
2023-02-14 |
13G/A
|
CGEM / Cullinan Therapeutics, Inc.
|
|
5,369,459 |
7,509,059 |
|
|
|
2023-02-14 |
13G/A
|
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
|
|
|
6,260,311 |
|
|
|
2023-02-14 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
|
488,367 |
|
|
|
2023-02-14 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
3,411,520 |
0 |
|
|
|
2023-02-14 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
3,160,416 |
3,347,946 |
|
|
|
2023-02-14 |
13G/A
|
ANTX / AN2 Therapeutics, Inc.
|
|
1,616,665 |
1,563,963 |
|
|
|
2023-02-14 |
13G/A
|
RNTX / Rein Therapeutics Inc.
|
|
|
236,835 |
|
|
|
2023-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
2,202,315 |
2,302,094 |
|
|
|
2023-02-14 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
3,868,043 |
3,276,543 |
|
|
|
2023-02-14 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
4,305,540 |
1,271,243 |
|
|
|
2023-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
3,027,672 |
2,258,400 |
|
|
|
2023-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
3,731,744 |
3,833,785 |
|
|
|
2023-02-14 |
13G/A
|
ACIU / AC Immune SA
|
|
7,062,379 |
7,428,379 |
|
|
|
2023-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
8,141,988 |
8,291,988 |
|
|
|
2023-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
1,589,495 |
1,353,815 |
|
|
|
2023-02-14 |
13G/A
|
ANNX / Annexon, Inc.
|
|
3,343,194 |
3,780,694 |
|
|
|
2023-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
3,596,757 |
4,917,774 |
|
|
|
2023-02-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
1,611,698 |
2,312,200 |
|
|
|
2023-02-14 |
13G/A
|
EYRYY / Erytech Pharma
|
|
2,299,301 |
517,242 |
|
|
|
2023-02-14 |
13G/A
|
IKNA / Ikena Oncology, Inc.
|
|
1,798,371 |
2,503,071 |
|
|
|
2023-02-14 |
13G/A
|
PYXS / Pyxis Oncology, Inc.
|
|
1,791,351 |
2,938,851 |
|
|
|
2023-02-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
1,929,201 |
1,810,835 |
|
|
|
2023-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
3,547,083 |
3,800,983 |
|
|
|
2023-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
4,891,945 |
1,250,000 |
|
|
|
2023-02-14 |
13G/A
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
14,360,000 |
16,149,179 |
|
|
|
2023-02-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
6,631,051 |
6,851,051 |
|
|
|
2023-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
3,379,599 |
5,246,565 |
|
|
|
2023-02-14 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
7,406,643 |
7,694,060 |
|
|
|
2023-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
18,506,158 |
20,094,466 |
|
|
|
2023-02-13 |
13G
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
12,660,518 |
|
|
|
2023-02-06 |
13G
|
/ JASPER THERAPEUTICS INC
|
|
|
9,900,000 |
|
|
|
2023-01-03 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
5,870,000 |
|
|
|
2022-12-23 |
13G/A
|
EYRYY / Erytech Pharma
|
|
5,119,183 |
2,299,301 |
|
|
|
2022-12-21 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
3,501,814 |
4,365,933 |
|
|
|
2022-12-16 |
13G
|
NLSP / NLS Pharmaceutics AG
|
|
|
6,859,146 |
|
|
|
2022-12-05 |
13G
|
KURA / Kura Oncology, Inc.
|
|
1,245,912 |
3,547,083 |
|
|
|
2022-11-10 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
3,526,729 |
3,526,729 |
|
|
|
2022-11-07 |
13G
|
ARAV / Aravive, Inc.
|
|
|
6,109,058 |
|
|
|
2022-09-29 |
13G
|
ALLK / Allakos Inc.
|
|
|
5,006,921 |
|
|
|
2022-09-26 |
13G
|
THRD / Third Harmonic Bio, Inc.
|
|
|
3,501,814 |
|
|
|
2022-09-26 |
13G
|
PNT / POINT Biopharma Global Inc.
|
|
2,920,526 |
5,590,048 |
|
|
|
2022-08-26 |
13G
|
VIGL / Vigil Neuroscience, Inc.
|
|
|
2,739,727 |
|
|
|
2022-08-23 |
13D/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
4,138,758 |
4,692,604 |
|
|
|
2022-08-11 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
17,123,023 |
28,463,021 |
|
|
|
2022-07-29 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
5,803,700 |
6,595,801 |
|
|
|
2022-07-19 |
13G/A
|
CFRX / ContraFect Corp
|
|
3,972,300 |
1,847,299 |
|
|
|
2022-07-12 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
4,565,242 |
8,748,629 |
|
|
|
2022-07-11 |
13G
|
ETNB / 89bio, Inc.
|
|
|
3,898,000 |
|
|
|
2022-06-21 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
2,005,862 |
4,007,413 |
|
|
|
2022-06-16 |
13G
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
6,894,345 |
|
|
|
2022-06-06 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
4,858,761 |
8,141,988 |
|
|
|
2022-06-01 |
13D/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
3,586,658 |
4,138,758 |
|
|
|
2022-05-26 |
13G
|
ANNX / Annexon, Inc.
|
|
|
3,343,194 |
|
|
|
2022-05-02 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
1,929,201 |
|
|
|
2022-05-02 |
13G
|
IDYA / IDEAYA Biosciences, Inc.
|
|
559 |
1,964,859 |
|
|
|
2022-04-18 |
13D
|
MLTX / MoonLake Immunotherapeutics
|
|
|
21,751,284 |
|
|
|
2022-04-04 |
13G
|
/ AN2 THERAPEUTICS
|
|
|
1,616,665 |
|
|
|
2022-03-24 |
13G
|
TYRA / Tyra Biosciences, Inc.
|
|
|
2,472,327 |
|
|
|
2022-03-21 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
5,157,486 |
4,305,540 |
|
|
|
2022-03-14 |
13G
|
RCUS / Arcus Biosciences, Inc.
|
|
2,752,222 |
3,960,948 |
|
|
|
2022-02-14 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
8,383,645 |
6,353,645 |
|
|
|
2022-02-14 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,601,582 |
7,406,643 |
|
|
|
2022-02-14 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
3,499,346 |
5,157,486 |
|
|
|
2022-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
7,584,219 |
2,202,315 |
|
|
|
2022-02-14 |
13G/A
|
EYRYY / Erytech Pharma
|
|
4,081,941 |
5,119,183 |
|
|
|
2022-02-14 |
13G
|
ELEV / Elevation Oncology, Inc.
|
|
|
1,611,698 |
|
|
|
2022-02-14 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
3,705,289 |
4,565,242 |
|
|
|
2022-02-14 |
13G/A
|
ACIU / AC Immune SA
|
|
7,916,658 |
7,062,379 |
|
|
|
2022-02-14 |
13G
|
COGT / Cogent Biosciences, Inc.
|
|
3,114,250 |
3,114,532 |
|
|
|
2022-02-14 |
13G/A
|
IKNA / Ikena Oncology, Inc.
|
|
1,599,658 |
1,798,371 |
|
|
|
2022-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
1,814,308 |
3,731,744 |
|
|
|
2022-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
2,761,121 |
3,379,599 |
|
|
|
2022-02-14 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
2,768,278 |
3,411,520 |
|
|
|
2022-02-14 |
13G/A
|
CGEM / Cullinan Therapeutics, Inc.
|
|
4,394,459 |
5,369,459 |
|
|
|
2022-02-14 |
13G/A
|
SELB / Selecta Biosciences Inc
|
|
4,926,108 |
1,723,133 |
|
|
|
2022-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
1,137,764 |
1,589,495 |
|
|
|
2022-02-14 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
3,710,689 |
4,931,879 |
|
|
|
2022-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
7,050,464 |
9,661,235 |
|
|
|
2022-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,719,616 |
3,027,672 |
|
|
|
2022-02-14 |
13G/A
|
FWP / Forward Pharma A/S - ADR
|
|
10,194,786 |
7,193,088 |
|
|
|
2022-02-14 |
13G
|
BNOX / Bionomics Limited - Depositary Receipt (Common Stock)
|
|
|
170,089,885 |
|
|
|
2022-02-14 |
13G
|
GHRS / GH Research PLC
|
|
|
9,275,158 |
|
|
|
2022-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
1,787,559 |
559 |
|
|
|
2022-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
5,060,071 |
4,135,071 |
|
|
|
2022-02-14 |
13G/A
|
PNT / POINT Biopharma Global Inc.
|
|
2,920,526 |
2,920,526 |
|
|
|
2022-02-14 |
13G/A
|
RVMD / Revolution Medicines, Inc.
|
|
3,757,049 |
1,810,549 |
|
|
|
2022-02-14 |
13G/A
|
AADI / Aadi Bioscience, Inc.
|
|
1,147,052 |
899,392 |
|
|
|
2022-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
1,344,262 |
0 |
|
|
|
2022-02-14 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
2,898,797 |
1,370,947 |
|
|
|
2022-02-14 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
2,695,418 |
0 |
|
|
|
2022-02-14 |
13G/A
|
GNCA / Genocea Biosciences Inc
|
|
5,285,549 |
5,930,353 |
|
|
|
2022-02-14 |
13G/A
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
10,963,000 |
14,360,000 |
|
|
|
2022-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
4,274,965 |
4,891,945 |
|
|
|
2022-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
3,722,398 |
4,858,761 |
|
|
|
2022-01-31 |
13D/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
2,630,662 |
3,586,658 |
|
|
|
2022-01-28 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
1,448,020 |
2,326,710 |
|
|
|
2022-01-24 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
3,868,043 |
|
|
|
2022-01-18 |
13G
|
STRO / Sutro Biopharma, Inc.
|
|
1,854,162 |
3,160,416 |
|
|
|
2022-01-12 |
13G/A
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
2,498,901 |
4,526,282 |
|
|
|
2022-01-12 |
13G/A
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
2,498,901 |
3,101,282 |
|
|
|
2022-01-11 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
2,945,807 |
3,526,729 |
|
|
|
2022-01-11 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
195,326 |
1,448,020 |
|
|
|
2022-01-11 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
195,326 |
1,434,932 |
|
|
|
2022-01-10 |
13G/A
|
VSTM / Verastem, Inc.
|
|
11,180,994 |
18,506,158 |
|
|
|
2022-01-10 |
13G/A
|
VSTM / Verastem, Inc.
|
|
11,180,994 |
17,062,158 |
|
|
|
2022-01-03 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,919,471 |
5,803,700 |
|
|
|
2021-12-20 |
13G
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
1,647,400 |
|
|
|
2021-12-20 |
13G/A
|
CGEM / Cullinan Therapeutics, Inc.
|
|
2,606,806 |
4,394,459 |
|
|
|
2021-12-20 |
13G
|
PYXS / Pyxis Oncology, Inc.
|
|
|
1,791,351 |
|
|
|
2021-12-16 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
4,461,494 |
6,861,127 |
|
|
|
2021-12-02 |
13D/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
6,661,503 |
7,411,503 |
|
|
|
2021-11-15 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
0 |
3,596,757 |
|
|
|
2021-11-08 |
13G
|
CGEM / Cullinan Therapeutics, Inc.
|
|
|
2,606,806 |
|
|
|
2021-10-29 |
13G
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
3,003,879 |
|
|
|
2021-09-15 |
13G
|
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
|
|
|
2,498,901 |
|
|
|
2021-09-15 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
2,545,253 |
2,945,807 |
|
|
|
2021-09-07 |
13G
|
AADI / Aadi Bioscience, Inc.
|
|
|
1,147,052 |
|
|
|
2021-07-08 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
4,361,238 |
7,452,331 |
|
|
|
2021-07-07 |
13G/A
|
MRUS / Merus N.V.
|
|
5,805,571 |
5,060,071 |
|
|
|
2021-07-06 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
1,945,949 |
2,545,253 |
|
|
|
2021-07-06 |
13G
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
2,005,862 |
|
|
|
2021-05-25 |
13D/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
1,852,511 |
1,945,949 |
|
|
|
2021-05-17 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
|
3,757,049 |
|
|
|
2021-05-03 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
5,576,471 |
2,919,471 |
|
|
|
2021-04-29 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
3,226,769 |
1,787,559 |
|
|
|
2021-04-28 |
13D
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
1,852,511 |
|
|
|
2021-04-15 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
4,522,051 |
6,631,051 |
|
|
|
2021-04-15 |
13G/A
|
CFRX / ContraFect Corp
|
|
2,908,913 |
3,972,300 |
|
|
|
2021-04-05 |
13G
|
IKNA / Ikena Oncology, Inc.
|
|
|
1,599,658 |
|
|
|
2021-04-02 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
4,182,243 |
3,530,543 |
|
|
|
2021-03-16 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,972,191 |
3,722,398 |
|
|
|
2021-03-15 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
12,753,690 |
17,123,023 |
|
|
|
2021-03-10 |
13G
|
EYRYY / Erytech Pharma
|
|
4,081,941 |
4,081,941 |
|
|
|
2021-03-08 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
3,138,678 |
6,338,678 |
|
|
|
2021-03-05 |
13G
|
FVAM / 5:01 Acquisition Corp.
|
|
|
500,000 |
|
|
|
2021-02-19 |
13G
|
INFI / Infinity Pharmaceuticals Inc.
|
|
8,383,645 |
8,383,645 |
|
|
|
2021-02-16 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
1,814,308 |
1,814,308 |
|
|
|
2021-02-16 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
3,499,346 |
3,499,346 |
|
|
|
2021-02-16 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
2,096,708 |
7,050,464 |
|
|
|
2021-02-16 |
13G/A
|
/ Therapeutics Acquisition Corp. Class A
|
|
1,000,000 |
954,996 |
|
|
|
2021-02-16 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
2,028,405 |
2,768,278 |
|
|
|
2021-02-16 |
13G/A
|
FSTX / F-star Therapeutics Inc
|
|
25,844 |
25,844 |
|
|
|
2021-02-16 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,719,616 |
1,719,616 |
|
|
|
2021-02-16 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
4,274,965 |
4,274,965 |
|
|
|
2021-02-16 |
13D/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
10,726,968 |
8,383,645 |
|
|
|
2021-02-16 |
13G/A
|
88907J107 / Novus Therapeutics, Inc.
|
|
1,518,039 |
1,503,121 |
|
|
|
2021-02-16 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
3,895,026 |
1,814,308 |
|
|
|
2021-02-16 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
7,050,464 |
7,050,464 |
|
|
|
2021-02-16 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
2,768,278 |
2,768,278 |
|
|
|
2021-02-16 |
13G/A
|
FSTX / F-star Therapeutics Inc
|
|
951,701 |
25,844 |
|
|
|
2021-02-16 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
3,516,851 |
3,499,346 |
|
|
|
2021-02-16 |
13G/A
|
/ Therapeutics Acquisition Corp. Class A
|
|
954,996 |
954,996 |
|
|
|
2021-02-16 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,660,475 |
1,719,616 |
|
|
|
2021-02-16 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,332,630 |
4,274,965 |
|
|
|
2021-02-12 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
2,816,390 |
3,710,689 |
|
|
|
2021-02-12 |
13G/A
|
GNCA / Genocea Biosciences Inc
|
|
3,161,668 |
5,285,549 |
|
|
|
2021-02-12 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
2,368,392 |
1,854,162 |
|
|
|
2021-02-12 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,872,762 |
5,601,582 |
|
|
|
2021-02-12 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
1,944,546 |
2,972,191 |
|
|
|
2021-02-12 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
5,255,301 |
4,522,051 |
|
|
|
2021-02-12 |
13G/A
|
MRUS / Merus N.V.
|
|
4,990,571 |
5,805,571 |
|
|
|
2021-02-12 |
13G/A
|
KZR / Kezar Life Sciences, Inc.
|
|
2,039,788 |
0 |
|
|
|
2021-02-12 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
1,832,484 |
1,799,694 |
|
|
|
2021-02-12 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
1,089,983 |
1,344,262 |
|
|
|
2021-02-12 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
2,921,177 |
2,898,797 |
|
|
|
2021-02-12 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
3,368,758 |
4,461,494 |
|
|
|
2021-02-11 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
6,886,425 |
5,589,315 |
|
|
|
2021-02-11 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
4,626,411 |
5,576,471 |
|
|
|
2021-02-11 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
7,090,638 |
4,361,238 |
|
|
|
2021-02-11 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
3,608,332 |
2,761,121 |
|
|
|
2021-02-11 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
2,640,565 |
3,705,289 |
|
|
|
2021-02-11 |
13G/A
|
FWP / Forward Pharma A/S - ADR
|
|
14,092,736 |
10,194,786 |
|
|
|
2021-02-11 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
3,079,155 |
|
|
|
|
2021-02-11 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
7,361,801 |
9,544,262 |
|
|
|
2021-02-11 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
2,309,109 |
0 |
|
|
|
2021-02-11 |
13G/A
|
SURF / Surface Oncology Inc
|
|
2,125,650 |
0 |
|
|
|
2021-02-11 |
13G/A
|
MRSN / Mersana Therapeutics, Inc.
|
|
3,755,553 |
0 |
|
|
|
2021-02-11 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
3,224,172 |
3,226,769 |
|
|
|
2021-02-11 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,434,696 |
1,245,912 |
|
|
|
2021-02-11 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
4,154,000 |
3,114,250 |
|
|
|
2021-02-11 |
13G/A
|
CRIS / Curis, Inc.
|
|
3,650,000 |
626,945 |
|
|
|
2021-02-11 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,441,565 |
0 |
|
|
|
2021-02-11 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
2,740,000 |
0 |
|
|
|
2021-02-11 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
664,079 |
0 |
|
|
|
2021-02-11 |
13G/A
|
VSTM / Verastem, Inc.
|
|
6,328,994 |
11,180,994 |
|
|
|
2021-02-01 |
13G
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
1,263,678 |
3,138,678 |
|
|
|
2021-01-29 |
13D/A
|
EYRYY / Erytech Pharma
|
|
4,461,941 |
4,081,941 |
|
|
|
2021-01-26 |
13D/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
17,426,968 |
10,726,968 |
|
|
|
2021-01-19 |
13G
|
ALRN / Rein Therapeutics Inc.
|
|
|
5,265,555 |
|
|
|
2021-01-14 |
13G/A
|
ACIU / AC Immune SA
|
|
11,342,505 |
7,916,658 |
|
|
|
2021-01-13 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
7,358,019 |
2,728,035 |
|
|
|
2021-01-12 |
13D/A
|
EYRYY / Erytech Pharma
|
|
4,461,941 |
4,461,941 |
|
|
|
2021-01-11 |
13G
|
GRTS / Gritstone bio, Inc.
|
|
|
2,695,418 |
|
|
|
2020-12-30 |
13G/A
|
88907J107 / Novus Therapeutics, Inc.
|
|
1,514,519 |
1,518,039 |
|
|
|
2020-12-28 |
13G/A
|
88907J107 / Novus Therapeutics, Inc.
|
|
195,326 |
1,514,519 |
|
|
|
2020-12-21 |
13G
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
10,963,000 |
|
|
|
2020-12-15 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
4,182,243 |
4,182,243 |
|
|
|
2020-12-10 |
13G/A
|
RCUS / Arcus Biosciences, Inc.
|
|
3,579,023 |
2,752,222 |
|
|
|
2020-11-20 |
13D
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
6,661,503 |
|
|
|
2020-11-16 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
3,938,280 |
7,358,019 |
|
|
|
2020-11-13 |
13D/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
8,364,353 |
1,263,678 |
|
|
|
2020-11-12 |
13D/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
17,426,968 |
17,426,968 |
|
|
|
2020-11-12 |
13G/A
|
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
|
|
|
7,431,562 |
|
|
|
2020-11-10 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
3,188,948 |
4,626,411 |
|
|
|
2020-11-09 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
7,584,219 |
|
|
|
2020-11-03 |
13G/A
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
31,242,465 |
5,946,840 |
|
|
|
2020-10-20 |
13G
|
CFRX / ContraFect Corp
|
|
2,773,989 |
2,908,913 |
|
|
|
2020-10-13 |
13D/A
|
EYRYY / Erytech Pharma
|
|
4,547,662 |
4,461,941 |
|
|
|
2020-10-09 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
4,182,243 |
4,182,243 |
|
|
|
2020-10-08 |
13D/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
7,783,001 |
8,364,353 |
|
|
|
2020-10-05 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
1,336,556 |
195,326 |
|
|
|
2020-09-23 |
13D/A
|
XOMA / XOMA Royalty Corporation
|
|
1,503,565 |
4,182,243 |
|
|
|
2020-08-25 |
13D
|
KYMR / Kymera Therapeutics, Inc.
|
|
|
2,630,662 |
|
|
|
2020-08-25 |
13D
|
US74257L1089 / Principia Biopharma Inc.
|
|
5,231,900 |
5,231,900 |
|
|
|
2020-08-19 |
13G
|
US74257L1089 / Principia Biopharma Inc.
|
|
1,716,734 |
5,231,900 |
|
|
|
2020-07-20 |
13G
|
/ Therapeutics Acquisition Corp. Class A
|
|
|
1,000,000 |
|
|
|
2020-07-16 |
13G
|
COGT / Cogent Biosciences, Inc.
|
|
|
4,154,000 |
|
|
|
2020-06-30 |
13G
|
RPTX / Repare Therapeutics Inc.
|
|
1,944,546 |
1,944,546 |
|
|
|
2020-06-29 |
13G
|
RPTX / Repare Therapeutics Inc.
|
|
|
1,944,546 |
|
|
|
2020-06-26 |
13G
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
2,740,000 |
|
|
|
2020-06-25 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
|
1,089,983 |
|
|
|
2020-06-22 |
13G
|
CRIS / Curis, Inc.
|
|
|
3,650,000 |
|
|
|
2020-06-22 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
2,656,057 |
3,516,851 |
|
|
|
2020-06-22 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
1,436,429 |
3,224,172 |
|
|
|
2020-06-03 |
13G/A
|
MRUS / Merus N.V.
|
|
3,169,654 |
4,990,571 |
|
|
|
2020-06-02 |
13G/A
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
31,242,465 |
31,242,465 |
|
|
|
2020-06-01 |
13G/A
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
31,942,380 |
31,242,465 |
|
|
|
2020-05-29 |
13G
|
SURF / Surface Oncology Inc
|
|
|
2,125,650 |
|
|
|
2020-05-26 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
9,559,642 |
7,090,638 |
|
|
|
2020-05-22 |
13G
|
STRO / Sutro Biopharma, Inc.
|
|
|
2,368,392 |
|
|
|
2020-04-01 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
7,206,458 |
3,938,280 |
|
|
|
2020-03-16 |
13G
|
KURA / Kura Oncology, Inc.
|
|
1,998,276 |
2,434,696 |
|
|
|
2020-03-06 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
1,124,483 |
3,188,948 |
|
|
|
2020-03-04 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
12,753,690 |
12,753,690 |
|
|
|
2020-02-19 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,506,905 |
5,872,762 |
|
|
|
2020-02-18 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
2,028,405 |
2,028,405 |
|
|
|
2020-02-18 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
3,082,997 |
2,921,177 |
|
|
|
2020-02-15 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
|
2,028,405 |
|
|
|
2020-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
1,201,718 |
1,137,764 |
|
|
|
2020-02-14 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
2,904,684 |
3,368,758 |
|
|
|
2020-02-14 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
3,032,850 |
3,082,997 |
|
|
|
2020-02-14 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
664,079 |
|
|
|
2020-02-14 |
13G/A
|
FWP / Forward Pharma A/S - ADR
|
|
18,092,758 |
14,092,736 |
|
|
|
2020-02-14 |
13G/A
|
RCUS / Arcus Biosciences, Inc.
|
|
2,411,623 |
3,579,023 |
|
|
|
2020-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
4,150,639 |
7,206,458 |
|
|
|
2020-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
3,343,413 |
3,169,654 |
|
|
|
2020-02-14 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
3,079,155 |
|
|
|
2020-02-14 |
13G/A
|
ACIU / AC Immune SA
|
|
11,297,911 |
11,342,505 |
|
|
|
2020-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
6,687,523 |
0 |
|
|
|
2020-02-14 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
7,361,801 |
7,361,801 |
|
|
|
2020-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,408,187 |
0 |
|
|
|
2020-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
5,512,994 |
6,328,994 |
|
|
|
2020-02-14 |
13G/A
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
721,935 |
0 |
|
|
|
2020-02-14 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
1,878,508 |
1,832,484 |
|
|
|
2020-02-14 |
13G/A
|
VBIV / VBI Vaccines Inc.
|
|
5,216,857 |
0 |
|
|
|
2020-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
3,364,421 |
3,608,332 |
|
|
|
2020-02-14 |
13G/A
|
FSTX / F-star Therapeutics Inc
|
|
951,701 |
951,701 |
|
|
|
2020-02-14 |
13G/A
|
US74257L1089 / Principia Biopharma Inc.
|
|
1,636,850 |
1,716,734 |
|
|
|
2020-02-14 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
2,602,836 |
2,656,057 |
|
|
|
2020-02-14 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
3,895,026 |
11,653,925 |
|
|
|
2020-02-14 |
13G
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
31,942,477 |
31,942,380 |
|
|
|
2020-02-14 |
13G/A
|
GNCA / Genocea Biosciences Inc
|
|
7,614,455 |
3,161,668 |
|
|
|
2020-02-14 |
13G/A
|
ARQL / ArQule, Inc.
|
|
8,670,350 |
4,902,383 |
|
|
|
2020-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,292,416 |
1,660,475 |
|
|
|
2020-02-14 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
2,535,878 |
2,816,390 |
|
|
|
2020-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
1,051,940 |
2,096,708 |
|
|
|
2020-02-14 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
7,457,921 |
5,506,905 |
|
|
|
2020-02-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
3,772,000 |
5,255,301 |
|
|
|
2020-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,775,156 |
1,998,276 |
|
|
|
2020-02-14 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
4,518,861 |
6,886,425 |
|
|
|
2020-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,502,390 |
2,332,630 |
|
|
|
2020-02-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
1,606,817 |
2,309,109 |
|
|
|
2020-02-14 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
1,329,700 |
2,640,565 |
|
|
|
2020-02-14 |
13G/A
|
MRSN / Mersana Therapeutics, Inc.
|
|
4,926,419 |
3,755,553 |
|
|
|
2020-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
1,505,429 |
1,436,429 |
|
|
|
2020-02-14 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
6,750,482 |
9,559,642 |
|
|
|
2020-02-10 |
13G
|
KZR / Kezar Life Sciences, Inc.
|
|
|
2,039,788 |
|
|
|
2020-02-04 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
12,753,896 |
12,753,690 |
|
|
|
2020-02-04 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
594,397 |
1,441,565 |
|
|
|
2020-01-10 |
13D/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
17,151,968 |
17,426,968 |
|
|
|
2020-01-07 |
13G
|
SELB / Selecta Biosciences Inc
|
|
|
4,926,108 |
|
|
|
2019-12-27 |
13D
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
7,783,001 |
7,783,001 |
|
|
|
2019-12-26 |
13D
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
5,967,119 |
7,783,001 |
|
|
|
2019-11-12 |
13G/A
|
MRUS / Merus N.V.
|
|
4,514,913 |
3,343,413 |
|
|
|
2019-11-08 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
4,143,891 |
5,967,119 |
|
|
|
2019-10-28 |
13G
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
1,636,850 |
|
|
|
2019-10-09 |
13G/A
|
MRSN / Mersana Therapeutics, Inc.
|
|
2,500,000 |
4,926,419 |
|
|
|
2019-10-02 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
2,781,346 |
4,143,891 |
|
|
|
2019-09-23 |
13G
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
2,843,845 |
|
|
|
2019-09-16 |
13G/A
|
ACIU / AC Immune SA
|
|
7,455,534 |
11,297,911 |
|
|
|
2019-09-09 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
4,436,801 |
7,361,801 |
|
|
|
2019-08-15 |
13G
|
GLYC / GlycoMimetics, Inc.
|
|
497,474 |
4,436,801 |
|
|
|
2019-08-07 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
1,890,507 |
3,032,850 |
|
|
|
2019-07-03 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,785,487 |
1,408,187 |
|
|
|
2019-06-28 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
1,329,700 |
1,329,700 |
|
|
|
2019-06-27 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
580,367 |
1,329,700 |
|
|
|
2019-06-25 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
3,298,282 |
6,750,482 |
|
|
|
2019-06-07 |
13G
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
1,505,429 |
|
|
|
2019-05-20 |
13G
|
VSTM / Verastem, Inc.
|
|
3,513,994 |
5,512,994 |
|
|
|
2019-05-10 |
13G
|
88907J107 / Novus Therapeutics, Inc.
|
|
|
1,336,556 |
|
|
|
2019-04-26 |
13D/A
|
OMED / OptMed Inc
|
|
4,042,989 |
0 |
|
|
|
2019-04-23 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
1,292,416 |
|
|
|
2019-04-08 |
13G
|
BBI / Brickell Biotech Inc
|
|
2,279,059 |
2,279,059 |
|
|
|
2019-04-02 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,381,845 |
2,785,487 |
|
|
|
2019-03-26 |
13G
|
REPL / Replimune Group, Inc.
|
|
|
1,606,817 |
|
|
|
2019-03-21 |
13G/A
|
ACIU / AC Immune SA
|
|
5,663,760 |
7,455,534 |
|
|
|
2019-03-19 |
13D/A
|
BBI / Brickell Biotech Inc
|
|
2,278,598 |
2,279,059 |
|
|
|
2019-03-15 |
13D
|
OMED / OptMed Inc
|
|
4,042,989 |
4,042,989 |
|
|
|
2019-03-11 |
13G
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
2,500,000 |
|
|
|
2019-03-04 |
13G
|
OVID / Ovid Therapeutics Inc.
|
|
|
3,772,000 |
|
|
|
2019-03-01 |
13D/A
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
26,026,200 |
31,942,477 |
|
|
|
2019-02-25 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
5,185,383 |
0 |
|
|
|
2019-02-14 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
|
1,815,146 |
|
|
|
2019-02-14 |
13G/A
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
0 |
|
|
|
2019-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
5,515,256 |
4,150,639 |
|
|
|
2019-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
13,974,249 |
1,051,940 |
|
|
|
2019-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
3,570,362 |
3,895,026 |
|
|
|
2019-02-14 |
13G/A
|
OREX / Orexigen Therapeutics, Inc.
|
|
1,534,050 |
2,036,860 |
|
|
|
2019-02-14 |
13G/A
|
RLM / Realm Therapeutics plc
|
|
177,738,291 |
21,451,171 |
|
|
|
2019-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,617,967 |
2,502,390 |
|
|
|
2019-02-14 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
1,492,836 |
2,602,836 |
|
|
|
2019-02-14 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
3,233,618 |
2,535,878 |
|
|
|
2019-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
2,787,629 |
3,364,421 |
|
|
|
2019-02-14 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
1,954,254 |
1,890,507 |
|
|
|
2019-02-14 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
5,231,353 |
5,185,383 |
|
|
|
2019-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
3,914,913 |
4,514,913 |
|
|
|
2019-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
7,587,416 |
6,687,523 |
|
|
|
2019-02-14 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
3,599,317 |
2,781,346 |
|
|
|
2019-02-14 |
13G/A
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
1,112,300 |
721,935 |
|
|
|
2019-02-14 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
2,019,000 |
3,298,282 |
|
|
|
2019-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
2,737,000 |
3,513,994 |
|
|
|
2019-02-14 |
13G/A
|
OMED / OptMed Inc
|
|
4,271,289 |
4,042,989 |
|
|
|
2019-02-14 |
13G/A
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
1,048,076 |
1,878,508 |
|
|
|
2019-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
5,250,000 |
2,773,989 |
|
|
|
2019-02-14 |
13G/A
|
ARQL / ArQule, Inc.
|
|
12,076,844 |
8,670,350 |
|
|
|
2019-02-14 |
13G/A
|
GNCA / Genocea Biosciences Inc
|
|
7,500,000 |
7,614,455 |
|
|
|
2019-02-14 |
13G/A
|
RCUS / Arcus Biosciences, Inc.
|
|
2,421,440 |
2,411,623 |
|
|
|
2019-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,057,346 |
2,775,156 |
|
|
|
2019-02-14 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
4,620,462 |
4,518,861 |
|
|
|
2019-02-14 |
13G/A
|
FSTX / F-star Therapeutics Inc
|
|
823,474 |
951,701 |
|
|
|
2019-02-14 |
13G/A
|
FWP / Forward Pharma A/S - ADR
|
|
181,716,681 |
18,092,758 |
|
|
|
2019-02-14 |
13G/A
|
GTXOD / Metalert Inc
|
|
|
0 |
|
|
|
2019-02-14 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,626,295 |
7,457,921 |
|
|
|
2019-02-12 |
13G
|
ACIU / AC Immune SA
|
|
5,663,760 |
5,663,760 |
|
|
|
2019-02-11 |
13G
|
ACIU / AC Immune SA
|
|
|
5,663,760 |
|
|
|
2019-02-07 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,969,789 |
1,150,445 |
|
|
|
2019-02-07 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,969,789 |
1,381,845 |
|
|
|
2019-02-01 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
1,907,875 |
2,278,598 |
|
|
|
2019-02-01 |
13D
|
BBI / Brickell Biotech Inc
|
|
1,907,875 |
2,278,598 |
|
|
|
2019-01-28 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
1,201,718 |
|
|
|
2019-01-10 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
5,721,888 |
5,515,256 |
|
|
|
2018-12-28 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
2,904,684 |
2,904,684 |
|
|
|
2018-12-27 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
2,846,430 |
2,904,684 |
|
|
|
2018-12-26 |
13G
|
VBIV / VBI Vaccines Inc.
|
|
|
5,216,857 |
|
|
|
2018-11-26 |
13G
|
RCUS / Arcus Biosciences, Inc.
|
|
|
2,421,440 |
|
|
|
2018-11-21 |
13D/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
15,232,268 |
17,151,968 |
|
|
|
2018-11-08 |
13D/A
|
EYRYY / Erytech Pharma
|
|
36,306,621 |
4,547,662 |
|
|
|
2018-10-17 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
5,231,353 |
5,231,353 |
|
|
|
2018-10-17 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
10,000,000 |
580,367 |
|
|
|
2018-10-16 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
4,106,200 |
5,231,353 |
|
|
|
2018-10-04 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
2,155,324 |
3,599,317 |
|
|
|
2018-10-01 |
13G
|
MTEM / Molecular Templates, Inc.
|
|
|
2,787,629 |
|
|
|
2018-09-04 |
13G
|
CALA / Calithera Biosciences, Inc.
|
|
|
2,019,000 |
|
|
|
2018-09-04 |
13G
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
2,155,324 |
|
|
|
2018-08-10 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
1,467,967 |
2,617,967 |
|
|
|
2018-07-19 |
13D
|
EYRYY / Erytech Pharma
|
|
34,372,271 |
3,630,662 |
|
|
|
2018-07-19 |
13G
|
RLM / Realm Therapeutics plc
|
|
|
17,773,829 |
|
|
|
2018-07-12 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
4,679,562 |
5,626,295 |
|
|
|
2018-07-09 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
2,057,346 |
|
|
|
2018-07-02 |
13G/A
|
EYRYY / Erytech Pharma
|
|
9,301,751 |
3,437,227 |
|
|
|
2018-06-21 |
13D/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
11,276,508 |
15,232,268 |
|
|
|
2018-06-19 |
13G/A
|
MRUS / Merus N.V.
|
|
2,419,443 |
3,914,913 |
|
|
|
2018-06-04 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
2,846,430 |
|
|
|
2018-06-01 |
13G/A
|
ARQL / ArQule, Inc.
|
|
17,553,089 |
12,076,844 |
|
|
|
2018-05-29 |
13G
|
MEIP / MEI Pharma, Inc.
|
|
|
4,620,462 |
|
|
|
2018-05-24 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
1,467,967 |
|
|
|
2018-05-04 |
13G/A
|
FWP / Forward Pharma A/S - ADR
|
|
106,428,341 |
18,171,668 |
|
|
|
2018-04-16 |
13G
|
GLMD / Galmed Pharmaceuticals Ltd.
|
|
|
1,048,076 |
|
|
|
2018-04-12 |
13D
|
INFI / Infinity Pharmaceuticals Inc.
|
|
9,766,508 |
11,276,508 |
|
|
|
2018-04-10 |
13G
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
1,112,300 |
|
|
|
2018-03-29 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
3,588,830 |
1,492,836 |
|
|
|
2018-03-19 |
13G
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
|
1,954,254 |
|
|
|
2018-03-05 |
13G/A
|
MRUS / Merus N.V.
|
|
2,124,443 |
2,419,443 |
|
|
|
2018-02-23 |
13G
|
MRUS / Merus N.V.
|
|
|
2,124,443 |
|
|
|
2018-02-14 |
13G/A
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
2,218,514 |
|
|
|
2018-02-14 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
4,573,142 |
4,679,562 |
|
|
|
2018-02-14 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
3,043,805 |
3,588,830 |
|
|
|
2018-02-14 |
13G/A
|
FSTX / F-star Therapeutics Inc
|
|
652,676 |
823,474 |
|
|
|
2018-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
12,949,229 |
13,974,249 |
|
|
|
2018-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,026,998 |
1,124,483 |
|
|
|
2018-02-14 |
13G/A
|
FATE / Fate Therapeutics, Inc.
|
|
3,759,398 |
0 |
|
|
|
2018-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
|
556,683 |
|
|
|
2018-02-14 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
2,547,318 |
3,233,618 |
|
|
|
2018-02-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,904,600 |
594,397 |
|
|
|
2018-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,616,249 |
1,969,789 |
|
|
|
2018-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
7,798,572 |
7,587,416 |
|
|
|
2018-02-14 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
4,649,588 |
1,658,157 |
|
|
|
2018-02-14 |
13G/A
|
OMED / OptMed Inc
|
|
3,961,689 |
4,271,289 |
|
|
|
2018-02-14 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
2,454,786 |
497,474 |
|
|
|
2018-02-14 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
7,860,808 |
9,766,508 |
|
|
|
2018-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
5,427,313 |
5,721,888 |
|
|
|
2018-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
2,160,295 |
3,570,362 |
|
|
|
2018-02-12 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
8,596,357 |
12,753,896 |
|
|
|
2018-02-09 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
1,320,164 |
1,469,800 |
|
|
|
2018-02-09 |
13G
|
IMDZ / Immune Design Corp.
|
|
1,320,164 |
4,106,200 |
|
|
|
2018-01-29 |
13G
|
GNCA / Genocea Biosciences Inc
|
|
|
7,500,000 |
|
|
|
2018-01-26 |
13G
|
VSTM / Verastem, Inc.
|
|
|
2,737,000 |
|
|
|
2018-01-16 |
13G
|
EPIX / ESSA Pharma Inc.
|
|
|
10,000,000 |
|
|
|
2018-01-03 |
13G
|
FWP / Forward Pharma A/S - ADR
|
|
106,428,341 |
10,642,834 |
|
|
|
2018-01-02 |
13G
|
FWP / Forward Pharma A/S - ADR
|
|
|
106,428,341 |
|
|
|
2018-01-02 |
13G
|
EYRYY / Erytech Pharma
|
|
|
930,175 |
|
|
|
2017-12-13 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
2,826,282 |
2,454,786 |
|
|
|
2017-11-30 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
3,266,321 |
5,427,313 |
|
|
|
2017-11-17 |
13G/A
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
2,021,018 |
2,547,318 |
|
|
|
2017-11-17 |
13G
|
BBI / Brickell Biotech Inc
|
|
|
1,907,875 |
|
|
|
2017-11-14 |
13G
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
2,021,018 |
|
|
|
2017-11-09 |
13G
|
SPRO / Spero Therapeutics, Inc.
|
|
|
1,029,185 |
|
|
|
2017-10-20 |
13G/A
|
ARQL / ArQule, Inc.
|
|
17,553,114 |
17,553,089 |
|
|
|
2017-10-16 |
13G/A
|
ARQL / ArQule, Inc.
|
|
7,867,966 |
17,553,114 |
|
|
|
2017-08-11 |
13G
|
FSTX / F-star Therapeutics Inc
|
|
|
652,676 |
|
|
|
2017-08-08 |
13D
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
17,500,000 |
26,026,200 |
|
|
|
2017-07-28 |
13G
|
CFRX / ContraFect Corp
|
|
|
5,250,000 |
|
|
|
2017-07-27 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
661,200 |
|
|
|
2017-07-27 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
1,864,474 |
661,200 |
|
|
|
2017-07-24 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
3,278,900 |
12,949,229 |
|
|
|
2017-07-18 |
13G/A
|
CAPS / Capstone Holding Corp.
|
|
7,755,688 |
2,714,491 |
|
|
|
2017-06-30 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,026,998 |
2,026,998 |
|
|
|
2017-06-29 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
2,026,998 |
|
|
|
2017-06-14 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
|
8,596,357 |
|
|
|
2017-06-14 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
15,592,160 |
8,596,357 |
|
|
|
2017-05-31 |
13G/A
|
OMED / OptMed Inc
|
|
1,843,484 |
3,961,689 |
|
|
|
2017-05-30 |
13G/A
|
OMED / OptMed Inc
|
|
2,985,489 |
1,843,484 |
|
|
|
2017-05-15 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
4,851,691 |
3,266,321 |
|
|
|
2017-05-05 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
3,278,900 |
|
|
|
2017-05-03 |
13G/A
|
BPMC / Blueprint Medicines Corporation
|
|
3,255,280 |
1,928,546 |
|
|
|
2017-04-27 |
13G
|
OMED / OptMed Inc
|
|
1,812,005 |
2,985,489 |
|
|
|
2017-04-21 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
|
1,750,000 |
|
|
|
2017-04-10 |
13G
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
17,500,000 |
|
|
|
2017-02-21 |
13D
|
XOMA / XOMA Royalty Corporation
|
|
302,800 |
1,503,565 |
|
|
|
2017-02-14 |
13G/A
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
1,643,899 |
|
|
|
2017-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
1,864,474 |
|
|
|
2017-02-14 |
13G/A
|
BPMC / Blueprint Medicines Corporation
|
|
2,840,251 |
3,255,280 |
|
|
|
2017-02-14 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
2,447,415 |
2,826,282 |
|
|
|
2017-02-14 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
1,339,792 |
1,320,164 |
|
|
|
2017-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
7,229,952 |
7,798,572 |
|
|
|
2017-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,232,014 |
2,616,249 |
|
|
|
2017-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
1,546,743 |
1,864,474 |
|
|
|
2017-02-14 |
13G/A
|
/ Array BioPharma, Inc.
|
|
7,850,211 |
4,986,186 |
|
|
|
2017-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
8,902,230 |
2,160,295 |
|
|
|
2017-02-14 |
13G/A
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
2,061,325 |
0 |
|
|
|
2017-02-14 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
3,108,905 |
3,043,805 |
|
|
|
2017-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
3,908,329 |
4,851,691 |
|
|
|
2017-02-14 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
1,161,234 |
0 |
|
|
|
2017-02-14 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
4,582,033 |
4,649,588 |
|
|
|
2017-02-14 |
13G/A
|
ARQL / ArQule, Inc.
|
|
6,809,843 |
7,867,966 |
|
|
|
2017-02-14 |
13G/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
4,778,999 |
4,573,142 |
|
|
|
2017-02-14 |
13G/A
|
GTXI / GTx, Inc.
|
|
|
1,643,899 |
|
|
|
2017-02-03 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
|
1,904,600 |
|
|
|
2017-02-02 |
13D/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
4,851,595 |
6,008,224 |
|
|
|
2017-02-02 |
13G
|
CASC / Cascadian Therapeutics, Inc.
|
|
4,851,595 |
6,008,224 |
|
|
|
2017-02-02 |
13D/A
|
ONTY / Oncothyreon, Inc.
|
|
4,851,595 |
6,008,224 |
|
|
|
2017-02-02 |
13G
|
ONTY / Oncothyreon, Inc.
|
|
6,008,224 |
6,008,224 |
|
|
|
2017-01-17 |
13D/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
27,773,238 |
4,851,595 |
|
|
|
2017-01-17 |
13D/A
|
ONTY / Oncothyreon, Inc.
|
|
27,773,238 |
4,851,595 |
|
|
|
2016-12-30 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
5,050,000 |
7,860,808 |
|
|
|
2016-12-01 |
13G
|
FATE / Fate Therapeutics, Inc.
|
|
|
3,759,398 |
|
|
|
2016-11-18 |
13G
|
XOMA / XOMA Royalty Corporation
|
|
|
302,800 |
|
|
|
2016-11-14 |
13G
|
IMDZ / Immune Design Corp.
|
|
|
1,339,792 |
|
|
|
2016-09-22 |
13G/A
|
TBRA / Tobira Therapeutics, Inc.
|
|
2,136,204 |
399,433 |
|
|
|
2016-09-16 |
13G
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
4,582,033 |
|
|
|
2016-09-12 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
1,775,572 |
3,108,905 |
|
|
|
2016-09-01 |
13G/A
|
TBRA / Tobira Therapeutics, Inc.
|
|
1,253,401 |
2,136,204 |
|
|
|
2016-08-26 |
13G
|
OMED / OptMed Inc
|
|
|
1,812,005 |
|
|
|
2016-07-19 |
13G
|
OREX / Orexigen Therapeutics, Inc.
|
|
|
1,534,050 |
|
|
|
2016-07-05 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
5,364,385 |
2,255,476 |
|
|
|
2016-06-27 |
13D/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
18,799,368 |
27,773,238 |
|
|
|
2016-06-27 |
13G
|
GLYC / GlycoMimetics, Inc.
|
|
|
2,447,415 |
|
|
|
2016-06-24 |
13G
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
5,050,000 |
|
|
|
2016-06-17 |
13G
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
4,778,999 |
|
|
|
2016-05-03 |
13G/A
|
BPMC / Blueprint Medicines Corporation
|
|
2,278,459 |
2,840,251 |
|
|
|
2016-03-22 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
1,546,743 |
|
|
|
2016-03-22 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
1,195,013 |
1,546,743 |
|
|
|
2016-03-18 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
1,125,572 |
1,775,572 |
|
|
|
2016-03-03 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
3,841,680 |
3,908,329 |
|
|
|
2016-02-16 |
13G/A
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
14,348,640 |
|
|
|
2016-02-16 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
821,264 |
1,125,572 |
|
|
|
2016-02-16 |
13G/A
|
LOXO / Loxo Oncology, Inc.
|
|
|
711,067 |
|
|
|
2016-02-16 |
13G/A
|
BPMC / Blueprint Medicines Corporation
|
|
1,695,408 |
2,278,459 |
|
|
|
2016-02-16 |
13G/A
|
PTN / Palatin Technologies, Inc.
|
|
|
3,400,000 |
|
|
|
2016-02-16 |
13G/A
|
SPHS / Sophiris Bio Inc
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
CAPS / Capstone Holding Corp.
|
|
|
7,755,688 |
|
|
|
2016-02-16 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
431,035 |
|
|
|
2016-02-16 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,390,408 |
2,232,014 |
|
|
|
2016-02-16 |
13G/A
|
TBRA / Tobira Therapeutics, Inc.
|
|
|
1,253,401 |
|
|
|
2016-02-16 |
13G/A
|
AOLS / Aeolus Pharmaceuticals, Inc.
|
|
|
15,213,480 |
|
|
|
2016-02-16 |
13G/A
|
GBIM / GlobeImmune, Inc.
|
|
678,400 |
657,653 |
|
|
|
2016-02-16 |
13G/A
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
2,375,933 |
2,061,325 |
|
|
|
2016-02-16 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
1,156,480 |
1,161,234 |
|
|
|
2016-02-16 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
|
3,841,680 |
|
|
|
2016-02-16 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
8,902,230 |
|
|
|
2016-02-16 |
13G/A
|
ARQL / ArQule, Inc.
|
|
6,356,118 |
6,809,843 |
|
|
|
2016-02-05 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
4,832,263 |
7,229,952 |
|
|
|
2016-02-05 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
7,850,211 |
|
|
|
2016-01-14 |
13D/A
|
TRGT / Targacept
|
|
|
44,796,940 |
|
|
|
2016-01-14 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
15,592,160 |
44,796,940 |
|
|
|
2016-01-12 |
13D/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
18,799,368 |
18,799,368 |
|
|
|
2016-01-11 |
13D/A
|
TRGT / Targacept
|
|
|
44,796,940 |
|
|
|
2016-01-11 |
13D/A
|
CTIC / CTI BioPharma Corp
|
|
|
44,796,940 |
|
|
|
2016-01-11 |
13D/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
18,799,368 |
18,799,368 |
|
|
|
2015-12-31 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
5,364,385 |
|
|
|
2015-12-21 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
1,195,013 |
|
|
|
2015-12-21 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
1,195,013 |
|
|
|
2015-12-21 |
13D
|
CASC / Cascadian Therapeutics, Inc.
|
|
14,588,796 |
18,799,368 |
|
|
|
2015-12-11 |
13D
|
TRGT / Targacept
|
|
|
|
|
|
|
2015-12-11 |
13D
|
CTIC / CTI BioPharma Corp
|
|
14,897,559 |
|
|
|
|
2015-12-07 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
10,000,000 |
43,795,613 |
|
|
|
2015-11-09 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
|
4,832,263 |
|
|
|
2015-10-02 |
13G
|
CTIC / CTI BioPharma Corp
|
|
|
10,000,000 |
|
|
|
2015-09-30 |
13G/A
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
2,375,933 |
|
|
|
2015-08-21 |
13D/A
|
CBIO / Crescent Biopharma, Inc.
|
|
7,020,128 |
1,156,480 |
|
|
|
2015-08-21 |
13G
|
CBIO / Crescent Biopharma, Inc.
|
|
7,020,128 |
1,156,480 |
|
|
|
2015-08-18 |
13G/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
9,561,363 |
14,588,796 |
|
|
|
2015-08-07 |
13D/A
|
TRGT / Targacept
|
|
|
7,020,128 |
|
|
|
2015-08-07 |
13D/A
|
CBIO / Crescent Biopharma, Inc.
|
|
6,655,128 |
7,020,128 |
|
|
|
2015-07-10 |
13G
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
821,264 |
|
|
|
2015-06-05 |
13G
|
GBIM / GlobeImmune, Inc.
|
|
|
678,400 |
|
|
|
2015-05-28 |
13G/A
|
ARQL / ArQule, Inc.
|
|
|
6,356,118 |
|
|
|
2015-05-28 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
2,390,408 |
|
|
|
2015-05-18 |
13G/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
9,561,363 |
|
|
|
2015-05-15 |
13D/A
|
TRGT / Targacept
|
|
|
6,655,128 |
|
|
|
2015-05-15 |
13D/A
|
CBIO / Crescent Biopharma, Inc.
|
|
|
6,655,128 |
|
|
|
2015-05-08 |
13G
|
BPMC / Blueprint Medicines Corporation
|
|
|
1,695,408 |
|
|
|
2015-03-18 |
13D/A
|
TRGT / Targacept
|
|
|
6,655,128 |
|
|
|
2015-03-18 |
13D/A
|
CBIO / Crescent Biopharma, Inc.
|
|
|
6,655,128 |
|
|
|
2015-02-17 |
13G/A
|
PTN / Palatin Technologies, Inc.
|
|
|
3,400,000 |
|
|
|
2015-02-17 |
13G/A
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
860,063 |
|
|
|
2015-02-17 |
13G
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
1,530,935 |
|
|
|
2015-02-17 |
13G/A
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
753,935 |
|
|
|
2015-02-17 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
826,332 |
|
|
|
2015-02-17 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
5,093,810 |
|
|
|
2015-02-17 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
618,224 |
|
|
|
2015-02-17 |
13G/A
|
LOXO / Loxo Oncology, Inc.
|
|
|
1,190,702 |
|
|
|
2015-02-17 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
|
8,596,772 |
|
|
|
2015-02-17 |
13G/A
|
RCPT / Receptos, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
AOLS / Aeolus Pharmaceuticals, Inc.
|
|
|
14,046,821 |
|
|
|
2015-02-17 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
3,136,000 |
|
|
|
2015-02-17 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
|
3,364,152 |
|
|
|
2015-02-17 |
13G/A
|
CAPS / Capstone Holding Corp.
|
|
|
7,755,688 |
|
|
|
2015-02-17 |
13G/A
|
TBRA / Tobira Therapeutics, Inc.
|
|
|
1,882,521 |
|
|
|
2015-02-17 |
13G/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
13,762,260 |
|
|
|
2015-02-17 |
13G/A
|
ARQL / ArQule, Inc.
|
|
|
4,723,811 |
|
|
|
2015-02-17 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
11,772,335 |
|
|
|
2015-02-10 |
13D
|
TRGT / Targacept
|
|
|
6,655,128 |
|
|
|
2015-01-08 |
13G
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
2,650,563 |
|
|
|
2014-12-24 |
13G
|
SPHS / Sophiris Bio Inc
|
|
|
1,060,283 |
|
|
|
2014-12-12 |
13G
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
1,368,500 |
|
|
|
2014-11-24 |
13G
|
GTXO / GTX Corp
|
|
|
11,111,111 |
|
|
|
2014-11-14 |
13G
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
703,724 |
|
|
|
2014-11-14 |
13G
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
3,166,000 |
|
|
|
2014-10-23 |
13G
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
900,935 |
|
|
|
2014-09-15 |
13G/A
|
PTN / Palatin Technologies, Inc.
|
|
|
4,150,655 |
|
|
|
2014-09-12 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
1,206,459 |
|
|
|
2014-09-05 |
13D
|
TRGT / Targacept
|
|
|
6,655,128 |
|
|
|
2014-08-22 |
13G
|
RCPT / Receptos, Inc.
|
|
|
1,434,600 |
|
|
|
2014-08-21 |
13G/A
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
1,408,599 |
|
|
|
2014-08-15 |
13G
|
ARQL / ArQule, Inc.
|
|
|
4,300,887 |
|
|
|
2014-08-11 |
13G
|
LOXO / Loxo Oncology, Inc.
|
|
|
1,205,000 |
|
|
|
2014-06-27 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
14,715,786 |
|
|
|
2014-05-09 |
13G
|
CYTK / Cytokinetics, Incorporated
|
|
|
2,238,052 |
|
|
|
2014-03-25 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
|
1,796,557 |
|
|
|
2014-03-25 |
13G/A
|
TBRA / Tobira Therapeutics, Inc.
|
|
|
2,330,393 |
|
|
|
2014-03-12 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
2,576,707 |
|
|
|
2014-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
|
233,689 |
|
|
|
2014-02-14 |
13G/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
14,001,778 |
|
|
|
2014-02-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
7,943,215 |
|
|
|
2014-02-14 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
7,553,089 |
|
|
|
2014-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
|
7,796,516 |
|
|
|
2014-02-14 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
2,370,263 |
|
|
|
2014-02-14 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
2,880,817 |
|
|
|
2014-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
|
3,289,957 |
|
|
|
2014-02-14 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
9,575,649 |
|
|
|
2014-02-14 |
13G/A
|
AOLS / Aeolus Pharmaceuticals, Inc.
|
|
|
17,147,178 |
|
|
|
2014-02-14 |
13G
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
1,136,000 |
|
|
|
2014-02-14 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
0 |
|
|
|
2014-02-04 |
13G/A
|
TBRA / Tobira Therapeutics, Inc.
|
|
|
3,659,091 |
|
|
|
2013-12-06 |
13G/A
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
2,626,160 |
|
|
|
2013-08-23 |
13G
|
TBRA / Tobira Therapeutics, Inc.
|
|
|
1,750,000 |
|
|
|
2013-06-07 |
13G/A
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
8,093,278 |
|
|
|
2013-05-15 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
9,697,997 |
|
|
|
2013-03-01 |
13G
|
AOLS / Aeolus Pharmaceuticals, Inc.
|
|
|
17,440,552 |
|
|
|
2013-02-15 |
13G
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
2,885,914 |
|
|
|
2013-02-14 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
|
15,839,746 |
|
|
|
2013-02-14 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
|
2,734,724 |
|
|
|
2013-02-14 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
|
5,026,766 |
|
|
|
2013-02-14 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
4,372,000 |
|
|
|
2013-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
|
2,718,200 |
|
|
|
2013-02-14 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
|
3,257,327 |
|
|
|
2013-02-14 |
13G/A
|
MYRX / Myrexis, Inc.
|
|
|
1,673,486 |
|
|
|
2013-02-14 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
5,287,127 |
|
|
|
2013-02-14 |
13G/A
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
3,582,065 |
|
|
|
2013-02-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
7,867,997 |
|
|
|
2013-02-14 |
13G/A
|
TRGT / Targacept
|
|
|
6,171,669 |
|
|
|
2013-02-14 |
13G/A
|
ECYT / Endocyte, Inc.
|
|
|
1,639,000 |
|
|
|
2013-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
216,581 |
|
|
|
2013-02-14 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
1,116,600 |
|
|
|
2012-11-19 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
11,431,858 |
|
|
|
2012-11-16 |
13G/A
|
TRGT / Targacept
|
|
|
5,430,869 |
|
|
|
2012-11-05 |
13G
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
4,117,827 |
|
|
|
2012-10-15 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
3,000,000 |
|
|
|
2012-09-10 |
13G/A
|
TRGT / Targacept
|
|
|
3,662,740 |
|
|
|
2012-08-31 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
|
4,986,766 |
|
|
|
2012-07-16 |
13G
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
4,173,500 |
|
|
|
2012-07-03 |
13G
|
CYTK / Cytokinetics, Incorporated
|
|
|
13,771,847 |
|
|
|
2012-06-18 |
13G
|
ECYT / Endocyte, Inc.
|
|
|
1,879,300 |
|
|
|
2012-05-29 |
13G
|
CCXI / ChemoCentryx Inc
|
|
|
2,250,899 |
|
|
|
2012-05-15 |
13G/A
|
TRGT / Targacept
|
|
|
1,746,940 |
|
|
|
2012-04-20 |
13G
|
SAVA / Cassava Sciences, Inc.
|
|
|
2,555,827 |
|
|
|
2012-02-10 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
8,223,469 |
|
|
|
2012-02-10 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
6,964,590 |
|
|
|
2012-02-10 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
2,184,908 |
|
|
|
2012-02-10 |
13G/A
|
RGEN / Repligen Corporation
|
|
|
0 |
|
|
|
2012-02-10 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
|
7,639,000 |
|
|
|
2012-02-10 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
19,950,001 |
|
|
|
2012-02-10 |
13G/A
|
TRGT / Targacept
|
|
|
3,267,602 |
|
|
|
2012-02-10 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
5,928,865 |
|
|
|
2012-02-10 |
13G/A
|
ASTX / Investment Managers Series Trust II - Tradr 2X Long ASTS Daily ETF
|
|
|
0 |
|
|
|
2012-02-10 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
1,194,100 |
|
|
|
2000-02-01 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
|
1,507,547 |
|
|
|
1999-10-14 |
13G
|
IMGN / ImmunoGen, Inc.
|
|
|
3,764,705 |
|
|
|